Gene Predictis Overview
- Year Founded
-
2004
- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
4
Gene Predictis General Information
Description
Developer of polygenic and multifactorial risk scores intended for interpreting complex genetic data. The company develops precision medicines and other diagnostic tools based on genetics that allow tailored treatments to improve drug treatment efficacy and significantly reduce harmful side effects resulting from adverse drug reactions for patients, thus providing physicians with genetic and molecular microbiology analyses for precise clinical results.
Contact Information
Website
www.genepredictis.com(Operating Subsidiary)
Corporate Office
- EPFL Innovation Park
- Building B
- 1015 Lausanne
- Switzerland
Corporate Office
- EPFL Innovation Park
- Building B
- 1015 Lausanne
- Switzerland
Gene Predictis Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Gene Predictis Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Gene Predictis Patents
Gene Predictis Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3333267-A1 | Method and kit for predicting the risk of deep vein thrombosis and pulmonary embolism | Inactive | 09-Dec-2016 | 0000000000 | 0 |
Gene Predictis Executive Team (5)
| Name | Title | Board Seat |
|---|---|---|
| Tanguy Araud Ph.D | Chief Operating Officer & Switzerland Medical Director | |
| Thierry Pache Ph.D | Co-Founder, Chairman & President | |
| Alain Mottaz Ph.D | Co-Founder |
Gene Predictis Board Members (9)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000-00000 0000000 | Self | Board Member | 000 0000 |
| 0000000 000000000 | Self | Board Member | 000 0000 |
| 0000000 000000ç00 | Self | Board Member | 000 0000 |
| 00000000 0000000 | Self | Board Member & Strategic Advisor | 000 0000 |
| 0000000 00000 00.0 | Gene Predictis | Co-Founder, Chairman & President | 000 0000 |
Gene Predictis Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Gene Predictis FAQs
-
When was Gene Predictis founded?
Gene Predictis was founded in 2004.
-
Who is the founder of Gene Predictis?
Thierry Pache Ph.D and Alain Mottaz Ph.D are the founders of Gene Predictis.
-
Where is Gene Predictis headquartered?
Gene Predictis is headquartered in Lausanne, Switzerland.
-
What industry is Gene Predictis in?
Gene Predictis’s primary industry is Biotechnology.
-
Is Gene Predictis a private or public company?
Gene Predictis is a Private company.
-
What is Gene Predictis’s current revenue?
The current revenue for Gene Predictis is 000000.
-
How much funding has Gene Predictis raised over time?
Gene Predictis has raised $497K.
-
Who are Gene Predictis’s investors?
EPFL Innovation Park has invested in Gene Predictis.
-
When was Gene Predictis acquired?
Gene Predictis was acquired on 13-Feb-2023.
-
Who acquired Gene Predictis?
Gene Predictis was acquired by NIMGenetics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
